Quantitative Analysis of the Policy of Centralized Drug Procurement Based on PMC Index Model

Abstract

Objective To quantitatively analyze the policy of centralized drug procurement centralized drug procurement in order to provide reference for the subsequent policy formulation and improvement. Methods Text mining method was used to process 15 centralized drugs procurement policies issued at the national level during 2015-2022, and a PMC index evaluation model of centralized drug procurement policies was established. Then, 15 centralized drug procurement policies were quantitatively analyzed from the overall and comparative perspective through an evaluation model. Results and Conclusion The average PMC index of 15 centralized drug procurement policies was 6.95, which was acceptable on the whole. Among them, eight were excellent and seven were acceptable. As to the first-order variables, the centralized drugs procurement policy still lacks incentives and constraints. The comparative results show that there are differences in the content and structure of policies, but they are strongly related to each other. Chinese centralized drug procurement policy has been basically formed, which is closely related to medical insurance and medical policies. However, it is still necessary to pay attention to the structure of the policy to ensure the elaboration of the policy content.

Keywords

centralized drug procurement / PMC index / policy / quantitative analysis

References

[1] Wang Biao, Zhang Tiantian, Tang Xiaoyu, et al. Study on price difference and regional distribution of selected drugs in China’s centralized procurement[J]. Chinese Journal of Health Policy, 2023, 16 (5): 29-33.

[2] Xu Yuan, Chen Minxing, He Jiangjiang, et al. Analysis and improvement suggestions of provincial drug centralized procurement policy under the new situation[J]. Chinese Health Economics, 2022, 41 (10): 17-20.

[3] Chen Miufeng, Xie Jinping, Wang Bin, et al. Study on the difference of implementation effect of procurement policy of different levels of hospitals in Changzhou[J]. Chinese Health Resources, 2022, 25 (6): 765-769+779.

[4] Chen Minxing, Wu Qingyi, Xu Yuan, et al. Analysis and suggestion on the policy of national centralized procurement of pharmaceutical products[J]. Chinese Health Resources, 2022, 25 (3): 273-277.

[5] Weng Bingbing, Jiang Hongli, Guo Yuan, et al. Local practice and exploration of centralized procurement of drugs with quantity[J]. Chinese Health Resources, 2022, 25 (6): 756-764.

[6] Song Jia, Fan Chengxin, Wang Wanchen, et al. From the perspective of stakeholders: A study on chinese drug procurement policy based on the text analysis of policy tools[J]. Chinese Journal of Health Policy, 2022, 15 (2): 11-17.

[7] Chen Jiaxin, Wu Tingting, Fu Manxia, et al. Quantitative evaluation of grouped payment policies based on PMC index model[J]. China Pharmacy, 2022, 33 (13): 1559-1564.

[8] Lan Yafei, Han Meng, Chen Ying, et al. Research on the evaluation of national industrial policy of traditional Chinese medicine - based on PMC index model[J]. Chinese Health Service Management, 2022, 39 (4): 280-286.

[9] Wu Qinde, Zhao Zijun, Xie Xianyu, et al. Analysis of Chinese DRG reform policy text based on PMC index model[J]. Chinese Health Economics, 2022, 41 (11): 8-12.

[10] Zhao Siqi, Liu Dongliang, Xia Yuqi, et al. Quantitative evaluation of chronic disease management policies in China based on PMC index model[J]. China Pharmacy, 2021, 32 (13): 1627-1633.

[11] Gao Xin, Sun Yuantai. Quantitative evaluation of rural revitalization policy text based on PMC index model[J]. Statistics & Decision, 2022, 38 (19): 57-60.

[12] Wang Xudong. Study on the policy of traditional Chinese medicine industry in Shanxi Province based on content analysis[J]. Journal of Traditional Chinese Medicine Management, 2022, 30 (9): 5-9.

[13] Dong Jichang, Yuan Quan, Yi Lijun, et al. Research on quantitative evaluation of single real estate policy based on PMC index model: A case study of housing rental policy since the 13th Five-Year Plan[J]. Business Review, 2020, 32 (5): 3-13+75.

[14] Zhai Yunkai, Guo Liuyan, Zhao Dongxiang, et al. Telemedicine policy evaluation based on PMC index model[J]. Journal of Information Resources Management, 2022, 12 (2): 112-122+137.

[15] Gu Yichun, He Da, Huang Jiasu, et al. Research on policy environment of Chinese health and medical big data development based on PMC index model[J]. Chinese Journal of Health Policy, 2022, 15 (4): 45-51.

[16] Lu Wei, Chen Hongdou, Li Wei, et al. Research on the accessibility of centralized procurement of drugs by national organizations: An empirical analysis based on the procurement data of public general hospitals across the country[J]. Chinese Journal of Hospital Pharmacy, 2019, 43 (17) : 1964-1969+1974.

[17] Li Xudong, Li Xin, Yu Qian, et al. Analysis on practice and effect of national collection of drugs based on information method[J]. China Pharmaceutical Affairs, 2021, 35 (2): 138-143.